{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T02:27:49Z","timestamp":1783823269615,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04279-8","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T09:04:56Z","timestamp":1751619896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Leveraging pathological markers of lower grade glioma to predict the occurrence of secondary epilepsy, a retrospective study"],"prefix":"10.1038","volume":"15","author":[{"given":"Zesheng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoguang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"4279_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","volume":"393","author":"RD Thijs","year":"2019","unstructured":"Thijs, R. D., Surges, R., O\u2019Brien, T. J. & Sander, J. W. Epilepsy in adults. Lancet 393, 689\u2013701 (2019).","journal-title":"Lancet"},{"key":"4279_CR2","doi-asserted-by":"publisher","first-page":"9015","DOI":"10.1038\/s41598-020-65768-6","volume":"10","author":"A Muhigwa","year":"2020","unstructured":"Muhigwa, A. et al. Comorbidities of epilepsy in low and middle-income countries: systematic review and meta-analysis. Sci. Rep. 10, 9015 (2020).","journal-title":"Sci. Rep."},{"key":"4279_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S1474-4422(15)00225-2","volume":"15","author":"MR Keezer","year":"2016","unstructured":"Keezer, M. R., Sisodiya, S. M. & Sander, J. W. Comorbidities of epilepsy: current concepts and future perspectives. Lancet Neurol. 15, 106\u2013115 (2016).","journal-title":"Lancet Neurol."},{"key":"4279_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2015.243","volume":"12","author":"AM Kanner","year":"2016","unstructured":"Kanner, A. M. Management of psychiatric and neurological comorbidities in epilepsy. Nat. Rev. Neurol. 12, 106\u2013116 (2016).","journal-title":"Nat. Rev. Neurol."},{"key":"4279_CR5","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/neuonc\/nov269","volume":"18","author":"TS Armstrong","year":"2016","unstructured":"Armstrong, T. S., Grant, R., Gilbert, M. R., Lee, J. W. & Norden, A. D. Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy. Neuro Oncol. 18, 779\u2013789 (2016).","journal-title":"Neuro Oncol."},{"key":"4279_CR6","doi-asserted-by":"publisher","first-page":"110092","DOI":"10.1016\/j.yebeh.2024.110092","volume":"160","author":"C Mann","year":"2024","unstructured":"Mann, C., Melzer, N. & M\u00fcnch, D. Epilepsy in LEAT and other brain tumors: A focused review. Epilepsy Behav. 160, 110092 (2024).","journal-title":"Epilepsy Behav."},{"key":"4279_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.nec.2018.09.001","volume":"30","author":"J Pallud","year":"2019","unstructured":"Pallud, J. & McKhann, G. M. diffuse low-grade glioma-related epilepsy. Neurosurg. Clin. N. Am. 30, 43\u201354 (2019).","journal-title":"Neurosurg. Clin. N. Am."},{"key":"4279_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/neuonc\/nox130","volume":"20","author":"X Shan","year":"2018","unstructured":"Shan, X. et al. Clinical characteristics associated with postoperative seizure control in adult low-grade gliomas: a systematic review and meta-analysis. Neuro Oncol. 20, 324\u2013331 (2018).","journal-title":"Neuro Oncol."},{"key":"4279_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/neuonc\/noad154","volume":"26","author":"EK Avila","year":"2024","unstructured":"Avila, E. K. et al. Brain tumor-related epilepsy management: A society for neuro-oncology (SNO) consensus review on current management. Neuro Oncol. 26, 7\u201324 (2024).","journal-title":"Neuro Oncol."},{"key":"4279_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/bs.pbr.2020.09.008","volume":"258","author":"C Li","year":"2020","unstructured":"Li, C. et al. The therapeutic and neuroprotective effects of an antiepileptic drug valproic acid in glioma patients. Prog. Brain Res. 258, 369\u2013379 (2020).","journal-title":"Prog. Brain Res."},{"key":"4279_CR11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1186\/s12885-023-11273-8","volume":"23","author":"EY Hattori","year":"2023","unstructured":"Hattori, E. Y. et al. Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy. BMC Cancer 23, 849 (2023).","journal-title":"BMC Cancer"},{"key":"4279_CR12","doi-asserted-by":"publisher","first-page":"e209352","DOI":"10.1212\/WNL.0000000000209352","volume":"102","author":"F Bruno","year":"2024","unstructured":"Bruno, F. et al. Association of clinical, tumor, and treatment characteristics with seizure control in patients with IDH1\/2-mutant lower-grade glioma. Neurology 102, e209352 (2024).","journal-title":"Neurology"},{"key":"4279_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.wneu.2024.09.084","volume":"193","author":"J Shi","year":"2024","unstructured":"Shi, J. et al. Comparative efficacy of neuromodulatory strategies for drug-resistant epilepsy: A systematic review and meta-analysis. World Neurosurg. 193, 373\u2013396 (2024).","journal-title":"World Neurosurg."},{"key":"4279_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.yebeh.2017.10.027","volume":"78","author":"A Neal","year":"2018","unstructured":"Neal, A. et al. IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy. Epilepsy Behav. 78, 30\u201336 (2018).","journal-title":"Epilepsy Behav."},{"key":"4279_CR15","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3171\/2023.11.FOCUS23678","volume":"56","author":"BC Bono","year":"2024","unstructured":"Bono, B. C. et al. The role of preoperative [11C]methionine PET in defining tumor-related epilepsy and predicting short-term postoperative seizure control in temporal lobe low-grade gliomas. Neurosurg. Focus 56, E6 (2024).","journal-title":"Neurosurg. Focus"},{"key":"4279_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","volume":"7","author":"A Vezzani","year":"2011","unstructured":"Vezzani, A., French, J., Bartfai, T. & Baram, T. Z. The role of inflammation in epilepsy. Nat. Rev. Neurol. 7, 31\u201340 (2011).","journal-title":"Nat. Rev. Neurol."},{"key":"4279_CR17","doi-asserted-by":"publisher","first-page":"e174753","DOI":"10.1172\/jci.insight.174753","volume":"9","author":"S Tripathi","year":"2024","unstructured":"Tripathi, S. et al. The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directions. JCI Insight 9, e174753 (2024).","journal-title":"JCI Insight"},{"issue":"24","key":"4279_CR18","doi-asserted-by":"publisher","first-page":"00737","DOI":"10.1016\/j.neuron.2024.10.016","volume":"S0896\u20136273","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Potassium ion channel modulation at cancer-neural interface enhances neuronal excitability in epileptogenic glioblastoma multiforme. Neuron S0896\u20136273(24), 00737\u201300742. https:\/\/doi.org\/10.1016\/j.neuron.2024.10.016 (2024).","journal-title":"Neuron"},{"key":"4279_CR19","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1093\/brain\/awac168","volume":"145","author":"BJA Gill","year":"2022","unstructured":"Gill, B. J. A. et al. Single unit analysis and wide-field imaging reveal alterations in excitatory and inhibitory neurons in glioma. Brain 145, 3666\u20133680 (2022).","journal-title":"Brain"},{"key":"4279_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41586-020-1952-2","volume":"578","author":"K Yu","year":"2020","unstructured":"Yu, K. et al. PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis. Nature 578, 166\u2013171 (2020).","journal-title":"Nature"},{"key":"4279_CR21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/brainsci12040504","volume":"12","author":"M Silva","year":"2022","unstructured":"Silva, M., Vivancos, C. & Duffau, H. The concept of \u00abPeritumoral zone\u00bb in diffuse low-grade gliomas: Oncological and functional implications for a connectome-guided therapeutic attitude. Brain Sci. 12, 504 (2022).","journal-title":"Brain Sci."},{"key":"4279_CR22","doi-asserted-by":"publisher","first-page":"e70172","DOI":"10.1111\/cns.70172","volume":"31","author":"J Shi","year":"2025","unstructured":"Shi, J. et al. Integrated Mendelian randomization and single-cell transcriptomics analysis identifies critical blood biomarkers and potential mechanisms in epilepsy. CNS Neurosci. Ther. 31, e70172 (2025).","journal-title":"CNS Neurosci. Ther."},{"key":"4279_CR23","doi-asserted-by":"publisher","first-page":"bbac191","DOI":"10.1093\/bib\/bbac191","volume":"23","author":"S Vadapalli","year":"2022","unstructured":"Vadapalli, S., Abdelhalim, H., Zeeshan, S. & Ahmed, Z. Artificial intelligence and machine learning approaches using gene expression and variant data for personalized medicine. Brief Bioinform. 23, bbac191 (2022).","journal-title":"Brief Bioinform."},{"key":"4279_CR24","doi-asserted-by":"publisher","first-page":"26503","DOI":"10.1038\/s41598-024-78553-6","volume":"14","author":"W DeGroat","year":"2024","unstructured":"DeGroat, W. et al. Multimodal AI\/ML for discovering novel biomarkers and predicting disease using multi-omics profiles of patients with cardiovascular diseases. Sci. Rep. 14, 26503 (2024).","journal-title":"Sci. Rep."},{"key":"4279_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-50600-8","volume":"14","author":"W DeGroat","year":"2024","unstructured":"DeGroat, W. et al. Discovering biomarkers associated and predicting cardiovascular disease with high accuracy using a novel nexus of machine learning techniques for precision medicine. Sci. Rep. 14, 1 (2024).","journal-title":"Sci. Rep."},{"key":"4279_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00784-023-05406-3","volume":"28","author":"Z Ahmed","year":"2024","unstructured":"Ahmed, Z., Degroat, W., Abdelhalim, H., Zeeshan, S. & Fine, D. Deciphering genomic signatures associating human dental oral craniofacial diseases with cardiovascular diseases using machine learning approaches. Clin. Oral Investig. 28, 52 (2024).","journal-title":"Clin. Oral Investig."},{"key":"4279_CR27","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cmi.2019.09.009","volume":"26","author":"N Peiffer-Smadja","year":"2020","unstructured":"Peiffer-Smadja, N. et al. Machine learning for clinical decision support in infectious diseases: a narrative review of current applications. Clin. Microbiol. Infect. 26, 584\u2013595 (2020).","journal-title":"Clin. Microbiol. Infect."},{"key":"4279_CR28","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41551-022-00914-1","volume":"6","author":"R Krishnan","year":"2022","unstructured":"Krishnan, R., Rajpurkar, P. & Topol, E. J. Self-supervised learning in medicine and healthcare. Nat. Biomed. Eng. 6, 1346\u20131352 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"4279_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12885-022-10385-x","volume":"23","author":"L Li","year":"2023","unstructured":"Li, L. et al. Development of an integrated predictive model for postoperative glioma-related epilepsy using gene-signature and clinical data. BMC Cancer 23, 42 (2023).","journal-title":"BMC Cancer"},{"key":"4279_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41698-024-00721-8","volume":"8","author":"J Li","year":"2024","unstructured":"Li, J. et al. Molecular mechanisms and diagnostic model of glioma-related epilepsy. NPJ Precis. Oncol. 8, 223 (2024).","journal-title":"NPJ Precis. Oncol."},{"key":"4279_CR31","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 23, 1231\u20131251 (2021).","journal-title":"Neuro Oncol."},{"key":"4279_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3171\/2020.12.JNS203351","volume":"136","author":"L Li","year":"2022","unstructured":"Li, L. et al. Glioma-related epilepsy in patients with diffuse high-grade glioma after the 2016 WHO update: seizure characteristics, risk factors, and clinical outcomes. J. Neurosurg. 136, 67\u201375 (2022).","journal-title":"J. Neurosurg."},{"key":"4279_CR33","doi-asserted-by":"publisher","first-page":"682535","DOI":"10.3389\/fneur.2021.682535","volume":"12","author":"L Li","year":"2021","unstructured":"Li, L. et al. New-onset postoperative seizures in patients with diffuse gliomas: A risk assessment analysis. Front. Neurol. 12, 682535 (2021).","journal-title":"Front. Neurol."},{"key":"4279_CR34","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/cns.14061","volume":"29","author":"X He","year":"2023","unstructured":"He, X. et al. Predictors of seizure outcomes in patients with diffuse low-grade glioma-related epilepsy after complete glioma removal. CNS Neurosci. Ther. 29, 736\u2013743 (2023).","journal-title":"CNS Neurosci. Ther."},{"key":"4279_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10014-021-00418-x","volume":"39","author":"T Nishikawa","year":"2022","unstructured":"Nishikawa, T. et al. Reliability of IDH1-R132H and ATRX and\/or p53 immunohistochemistry for molecular subclassification of Grade 2\/3 gliomas. Brain Tumor Pathol. 39, 14\u201324 (2022).","journal-title":"Brain Tumor Pathol."},{"key":"4279_CR36","doi-asserted-by":"publisher","first-page":"16384","DOI":"10.18632\/oncotarget.7650","volume":"7","author":"J Cai","year":"2016","unstructured":"Cai, J. et al. Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas. Oncotarget 7, 16384\u201316395 (2016).","journal-title":"Oncotarget"},{"key":"4279_CR37","first-page":"1790","volume":"8","author":"H Xie","year":"2015","unstructured":"Xie, H., Tubbs, R. & Yang, B. Detection of MGMT promoter methylation in glioblastoma using pyrosequencing. Int. J. Clin. Exp. Pathol. 8, 1790\u20131796 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"4279_CR38","first-page":"95","volume":"17","author":"J Liu","year":"2019","unstructured":"Liu, J. et al. Significance of TERT and ATRX mutations in glioma. Oncol. Lett. 17, 95\u2013102 (2019).","journal-title":"Oncol. Lett."},{"key":"4279_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Mach. Learn. 45, 5\u201332 (2001).","journal-title":"Mach. Learn."},{"key":"4279_CR40","doi-asserted-by":"publisher","first-page":"1375112","DOI":"10.3389\/fphar.2024.1375112","volume":"15","author":"Z Li","year":"2024","unstructured":"Li, Z., Wei, C., Zhang, Z. & Han, L. ecGBMsub: an integrative stacking ensemble model framework based on eccDNA molecular profiling for improving IDH wild-type glioblastoma molecular subtype classification. Front. Pharmacol. 15, 1375112 (2024).","journal-title":"Front. Pharmacol."},{"key":"4279_CR41","doi-asserted-by":"publisher","first-page":"216369","DOI":"10.1016\/j.canlet.2023.216369","volume":"574","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. A three-stage eccDNA based molecular profiling significantly improves the identification, prognosis assessment and recurrence prediction accuracy in patients with glioma. Cancer Lett. 574, 216369 (2023).","journal-title":"Cancer Lett."},{"key":"4279_CR42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10143-014-0539-5","volume":"37","author":"F Shen","year":"2014","unstructured":"Shen, F. et al. Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas. Neurosurg. Rev. 37, 367\u2013380 (2014).","journal-title":"Neurosurg. Rev."},{"key":"4279_CR43","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41698-024-00632-8","volume":"8","author":"D Yu","year":"2024","unstructured":"Yu, D. et al. Combination of MRI-based prediction and CRISPR\/Cas12a-based detection for IDH genotyping in glioma. NPJ Precis. Oncol. 8, 140 (2024).","journal-title":"NPJ Precis. Oncol."},{"key":"4279_CR44","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00415-021-10668-6","volume":"269","author":"M Marku","year":"2022","unstructured":"Marku, M. et al. Prediagnosis epilepsy and survival in patients with glioma: a nationwide population-based cohort study from 2009 to 2018. J. Neurol. 269, 861\u2013872 (2022).","journal-title":"J. Neurol."},{"key":"4279_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.clineuro.2016.07.003","volume":"148","author":"Z-F Wang","year":"2016","unstructured":"Wang, Z.-F. & Chen, H.-L. Relationship between IDH1 mutation and preoperative seizure in low-grade gliomas: A meta-analysis. Clin. Neurol. Neurosurg. 148, 79\u201384 (2016).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"4279_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.seizure.2018.01.011","volume":"55","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. IDH1 mutation is associated with a higher preoperative seizure incidence in low-grade glioma: A systematic review and meta-analysis. Seizure 55, 76\u201382 (2018).","journal-title":"Seizure"},{"key":"4279_CR47","doi-asserted-by":"publisher","first-page":"692751","DOI":"10.3389\/fneur.2021.692751","volume":"12","author":"L Song","year":"2021","unstructured":"Song, L., Quan, X., Chen, C., Chen, L. & Zhou, J. Correlation between tumor molecular markers and perioperative epilepsy in patients with glioma: A systematic review and meta-analysis. Front. Neurol. 12, 692751 (2021).","journal-title":"Front. Neurol."},{"key":"4279_CR48","doi-asserted-by":"publisher","first-page":"1291692","DOI":"10.3389\/fmicb.2023.1291692","volume":"14","author":"W Wang","year":"2023","unstructured":"Wang, W., Li, X., Ye, L. & Yin, J. A novel deep learning model for glioma epilepsy associated with the identification of human cytomegalovirus infection injuries based on head MR. Front. Microbiol. 14, 1291692 (2023).","journal-title":"Front. Microbiol."},{"key":"4279_CR49","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.nicl.2018.04.024","volume":"19","author":"Z Liu","year":"2018","unstructured":"Liu, Z. et al. Radiomics analysis allows for precise prediction of epilepsy in patients with low-grade gliomas. Neuroimage Clin. 19, 271\u2013278 (2018).","journal-title":"Neuroimage Clin."},{"key":"4279_CR50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jocn.2015.11.030","volume":"31","author":"Y Yang","year":"2016","unstructured":"Yang, Y. et al. An analysis of 170 glioma patients and systematic review to investigate the association between IDH-1 mutations and preoperative glioma-related epilepsy. J. Clin. Neurosci. 31, 56\u201362 (2016).","journal-title":"J. Clin. Neurosci."},{"key":"4279_CR51","doi-asserted-by":"publisher","first-page":"1288918","DOI":"10.3389\/fncel.2023.1288918","volume":"17","author":"D McAfee","year":"2023","unstructured":"McAfee, D. et al. Differential metabolic alterations in IDH1 mutant vs. wildtype glioma cells promote epileptogenesis through distinctive mechanisms. Front. Cell. Neurosci. 17, 1288918 (2023).","journal-title":"Front. Cell. Neurosci."},{"key":"4279_CR52","doi-asserted-by":"publisher","first-page":"106430","DOI":"10.1016\/j.eplepsyres.2020.106430","volume":"166","author":"S Shen","year":"2020","unstructured":"Shen, S. et al. Correlation of preoperative seizures with a wide range of tumor molecular markers in gliomas: An analysis of 442 glioma patients from China. Epilepsy Res. 166, 106430 (2020).","journal-title":"Epilepsy Res."},{"key":"4279_CR53","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s10014-021-00406-1","volume":"38","author":"Y Osada","year":"2021","unstructured":"Osada, Y. et al. Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma. Brain Tumor Pathol. 38, 218\u2013227 (2021).","journal-title":"Brain Tumor Pathol."},{"key":"4279_CR54","doi-asserted-by":"publisher","first-page":"155165","DOI":"10.1016\/j.prp.2024.155165","volume":"254","author":"T Tang","year":"2024","unstructured":"Tang, T. et al. IDH1 mutation predicts seizure occurrence and prognosis in lower-grade glioma adults. Pathol. Res. Pract. 254, 155165 (2024).","journal-title":"Pathol. Res. Pract."},{"key":"4279_CR55","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/1531-8249(200001)47:1<117::AID-ANA20>3.0.CO;2-A","volume":"47","author":"R Guerrini","year":"2000","unstructured":"Guerrini, R. et al. A nonsense mutation of the ATRX gene causing mild mental retardation and epilepsy. Ann. Neurol. 47, 117\u2013121 (2000).","journal-title":"Ann. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04279-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04279-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04279-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:31:26Z","timestamp":1752139886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04279-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4279"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04279-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of Xuanwu Hospital. Informed consent was obtained from all individual participants included in the study. All methods were performed in accordance with the guiding principles of the World Medical Association Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"23907"}}